Sernova Corp. (TSE:SVA – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as C$0.37 and last traded at C$0.37, with a volume of 144113 shares changing hands. The stock had previously closed at C$0.40.
Analyst Ratings Changes
Separately, Raymond James set a C$1.50 target price on shares of Sernova and gave the company a “market perform” rating in a research report on Thursday, April 4th.
Get Our Latest Analysis on Sernova
Sernova Price Performance
Sernova (TSE:SVA – Get Free Report) last announced its earnings results on Monday, March 18th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of C($0.03). On average, equities research analysts anticipate that Sernova Corp. will post -0.08 EPS for the current fiscal year.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
- Five stocks we like better than Sernova
- How to Choose Top Rated Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Value Stocks You Can Buy Before They Become Big
- Why Invest in 5G? How to Invest in 5G Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.